Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Hyun-Woong | - |
dc.contributor.author | Hong, Jin Hwa | - |
dc.contributor.author | Min, Kyung Jin | - |
dc.contributor.author | Ouh, Yung-Taek | - |
dc.contributor.author | Seong, Seok Ju | - |
dc.contributor.author | Moon, Jun Hye | - |
dc.contributor.author | Cho, Seong Hwan | - |
dc.contributor.author | Lee, Jae Kwan | - |
dc.date.accessioned | 2021-08-13T08:40:19Z | - |
dc.date.available | 2021-08-13T08:40:19Z | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 1598-2998 | - |
dc.identifier.issn | 2005-9256 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54007 | - |
dc.description.abstract | Purpose The study aimed to evaluate the diagnostic accuracy of polymerase chain reaction & ndash;based high-risk human papillomavirus (HPV) assays on self-collected vaginal and urine samples for detection of precancerous cervical lesions in referral population. Materials and Methods Women referred for colposcopy following abnormal cytology, were included this study. A total of 314 matched urine, vaginal, and cervical samples were collected. All samples were tested for HPV DNA using the RealTime HR-S HPV and Anyplex II HPV 28 assays. Primary endpoints were sensitivity for cervical intraepithelial neoplasia (CIN) 2+/CIN3+ and specificity for <CIN2.Secondary endpoints were the relative accuracy of high-risk HPV (hrHPV) test results in vaginal and urine samples versus cervical samples. Results The sensitivity of Realtime HR-s and Anyplex HPV assay was 93.13% (95% confidence interval [CI],87.36 to 96.81) and 90.08% (95% CI,0.70 to 0.92) and 0.74 (95% CI 0.61 to 0.89). Conclusion The detection performance for hrHPV and CIN2+ on self-collected vaginal samples was comperable to that of clinician-collected cervical samples .On the other hand ,HPV tests using urine were inferior to those using clincian-collected cervical samples in terms of detecting hrHPV and CIN2+. & nbsp; | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한암학회 | - |
dc.title | Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4143/crt.2020.1165 | - |
dc.identifier.scopusid | 2-s2.0-85111529135 | - |
dc.identifier.wosid | 000674117200025 | - |
dc.identifier.bibliographicCitation | Cancer Research and Treatment, v.53, no.3, pp 829 - 836 | - |
dc.citation.title | Cancer Research and Treatment | - |
dc.citation.volume | 53 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 829 | - |
dc.citation.endPage | 836 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002738749 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | CERVICAL-CANCER | - |
dc.subject.keywordPlus | HPV | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordAuthor | Cervical intraepithelial neoplasia | - |
dc.subject.keywordAuthor | Human papillomavirus DNA tests | - |
dc.subject.keywordAuthor | Specimen handling | - |
dc.subject.keywordAuthor | Urine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.